Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats

Experimental Neurology

Volumn 172, Issue 2, 2001, Pages 416-424

  Alemdar, A Y ^a   Baker, K A ^a   Sadi, D ^a   McAlister, V C ^b   Mendez, I ^a,c  

^a Neural Transplantation Laboratory   (Canada)

^b Division of General Surgery

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cell suspensions; Dopaminergic grafts; Immunosuppression; Liposome; Neural transplantation; Parkinson's disease; Tacrolimus

Indexed keywords

CYCLOSPORIN A; OXIDOPAMINE; TACROLIMUS; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MESENCEPHALON; MICELLE; MOUSE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; XENOGRAFT;

EID: 0035696058     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7801     Document Type: Article

References (52)

1. Estimation of nuclear population from microtome sections
2. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic neurons
3. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation
4. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease
5. Differentiation and histological analysis of embryonic stem cell-derived neural transplants in mice
6. CNS immunological modulation of neural graft rejection and survival
7. Cerebral ischemia and CNS transplantation: Differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line
8. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons
9. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
10. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons
11. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
12. FK506 accelerates functional recovery following nerve grafting in a rat model
13. Methyl prednisolone prevents rejection of intrastriatal grafts of xenogeneic tissue in adult rats
14. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic, or xenogeneic embryonic neuronal tissue in rats
15. Immune reactions following systemic immunization prior or subsequent to transplantation of allogeneic mesencephalic tissue in adult rats
16. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results
17. Transplantation of embryonic dopaminergic neurons for severe Parkinson's disease
18. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology
19. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506
20. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons
21. Implantation of xenogeneic transgeneic neural plate tissues into Parkinsonian rat brain
22. Human neural graft function in rats treated with anti-interleukin II receptor antibody
23. Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts
24. Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of the rat brain
25. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro
26. The enhanced immunosuppressive efficacy of newly developed liposomal FK-506 in canine liver transplants
27. The pharmacokinetic benefits of newly developed liposome-incorporated FK506
28. Transplantation of cultured human neuronal cells for patients with stroke
29. Mechanisms of allograft rejection in the rat brain
30. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia
31. Neural transplantation in Parkinson's disease
32. Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model
33. A microtransplantation approach for cell suspension grafting in the rat Parkinsonian model: A detailed account of the methodology
34. Fetal nigral transplantation as a therapy for Parkinson's disease
35. MHC antigen expression and cellular response in spontaneous and induced rejection from intracerebral neural xenografts in neonatal rats
36. Immunological reactions induced by intracerebral transplantation: Evidence that host microglia but not astroglia are the antigen-presenting cells
37. Survival and maturation of heterotopic fetal brain stem xenografts after treatment with 2-chlorodeoxyadenosine and cyclosporine A
38. The effect of the new immunosuppressive agent, FK-506, on xenogeneic neural transplants in rodents
39. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression
40. Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations: A potential role for islet transplantation in an immunologically privileged site
41. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin, and cyclosporin A
42. High brain densities of the immunophilin FKBP colocalized with calcineurin
43. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative models
44. Immunophilins in the nervous system
45. Neural stem cells in the developing central nervous system: Implications for cell therapy through transplantation
46. Direct isolation of human central nervous system stem cells
47. Peripheral-nerve allotransplantation in rats immunsuppressed with transient or long-term FK-506
48. Sertoli cells enhance the survival of cotransplanted dopamine neurons
49. Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum
50. A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: A time-course study
51. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies
52. Suppression of immunorejection against rat fetal dopaminergic neurons in a mouse brain by 15-deoxyspergualin